As of September 2023, Neurosetta became the exclusive licensee of US Patent #11,767,508, “Methods and culture substrates for controlled induction of biomimetic neural tissues comprising singular rosette structures” invented by Drs. Randolph Ashton and Gavin T. Knight. With this Intellectual Property protection, Neurosetta has established itself as the sole commercial provider of the RosetteArray™ platform for developmental neurotoxicity, disease modeling, and drug discovery applications.
